COVID-19 Information Center COVID-19 Situation Report, March 29, 2022 The total number of confirmed cases is 21,678, categorized as 21,614 domestic cases and 64 foreign patients, 27,183 recovered. Patients are being treated. 245,154 cases and 78 deaths, 1,748 pneumonia patients were hospitalized, an average of 23 per province, bed occupancy rate 28.3%, cumulative sickness (since Jan 1, 65), 1,351,963 cases, cumulative recovery (since Date 1 Jan. 65) 1,136,792 cases
The Ministry of Public Health has confirmed that there is enough favipiravir. There are 22.8 million tablets left nationwide.
How should cancer patients get vaccinated against COVID-19?
for the 10 provinces with the highest number of infections
1.Bangkok, 3,611 cases
2. Chonburi 1,089 cases
3. Nakhon Si Thammarat 880 cases
4. Samut Prakan 857 cases
5. Nonthaburi 730 cases
6. Samut Sakhon 690 cases
7. Rayong 570 cases
8. Buriram 540 cases
9. Songkhla 532 cases
10. Nakhon Pathom 511 cases
While the overview of the COVID-19 vaccination report (28 Feb 2021 – 28 Mar 2022) Total 128,882,039 doses in 77 provinces
Overview of vaccinations on March 28, 2022, the total number of vaccinations nationwide 121,596 doses.
Needle 1: 31,552 cases, cumulative: 55,353,039 cases
2nd needle: 10,320 cases, cumulative: 50,257,501 cases
Needle 3: 79,724 cases, cumulative: 23,271,499 cases
on the side of Dr. Thongchai Keeratihatthayakon Deputy Permanent Secretary, Ministry of Public Health (MoPH) spoke about the severe shortage of favipiravir drug used to treat coronavirus patients. According to data as of March 28, there are 22.8 million tablets of favipiravir in stock nationwide, with the current average usage of 2 million tablets, an increase of 2 million tablets per day, so there is a high rate of use. At 10 days, but we have more pills all the time. And the drug is distributed online in the system called “VMI” when the hospital uses the drug. will key data into the system how much is used will appear public information to know how much medicine is left Then it will be added to The Pharmaceutical Organization (GPO) will supply the refill drug.